Condition: Brain Metastases · Brain Metastases, Adult · Metastatic Brain Tumor · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to develop and test a new magnetic resonance imaging (MRI) technique to see if it can be used to tell the difference between tumor growth from worsening of cancer and growth from the effects of treatment in participants who have brain tumors treated with radiation therapy called stereotactic radiosurgery (SRS).
This description comes directly from the study's public registry record.
Ouri Cohen, PhD · 646-608-8259 · coheno1@mskcc.org
Nelson Moss, MD · 212-639-7075 · mossn@mskcc.org
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05559853